Status:
COMPLETED
Fluoride Therapies on Hypersensitive Carious Lesions in Primary Teeth
Lead Sponsor:
University Medicine Greifswald
Collaborating Sponsors:
SDI Limited
Conditions:
Dentin Hypersensitivity
Active Dental Caries
Eligibility:
All Genders
2-5 years
Phase:
PHASE2
PHASE3
Brief Summary
This observational cohort study aims to evaluate the short-term (3 months) efficacy of the standard fluoride therapy in the German National Health System for managing hypersensitive carious lesions in...
Detailed Description
A single trained investigator will screen for possible study participants of children aged 2-5 years old, and their parents will be asked to participate in the study. The participants will be consecut...
Eligibility Criteria
Inclusion
- Reported hypersensitivity in primary teeth associated with the presence of active carious lesions (ICDAS 5).
- Healthy children aged 2-5 years.
- Not using any desensitizer for 1-month prior the study.
- Willing to be examined.
Exclusion
- Previously restored teeth.
- Teeth with signs or symptoms of irreversible pulpitis.
- Patients with any systemic disease requiring special considerations during their dental treatment.
- Parents/children who declined to participate in the study.
Key Trial Info
Start Date :
January 13 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04804423
Start Date
January 13 2020
End Date
April 1 2021
Last Update
May 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Department of Preventive and Pediatric Dentistry, University of Greifswald
Greifswald, Mecklenburg-Vorpommern, Germany, 17475